Background The Streptococcus pneumoniae Invasive Disease network (SpIDnet) actively monitors populations in nine sites in seven European countries for invasive pneumococcal disease. Five sites use 13-valent pneumococcal conjugate vaccine (PCV13) alone and four use the ten-valent PCV (PCV10) and PCV13. Vaccination uptake is greater than 90% in six sites and 67–78% in three sites. We measured the effects of introducing high-valency PCVs on the incidence of invasive pneumococcal disease in children younger than 5 years. Methods We compared the incidence of invasive pneumococcal disease in each of the 4 years after the introduction of PCV13 alone or PCV10 and PCV13 with the average incidence during the preceding period of heptavalent PCV (...
BackgroundIn April 2010, a 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 for use in...
BACKGROUND: Pneumococcal conjugate vaccines (PCVs) have substantially reduced the incidence of invas...
<div><p>Background</p><p>The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into t...
Background: Pneumococcal conjugate vaccines covering 10 (PCV10) and 13 (PCV13) serotypes have been i...
Background: Pneumococcal conjugate vaccines covering 10 (PCV10) and 13 (PCV13) serotypes have been ...
BACKGROUND: The 7-valent pneumococcal conjugate (PCV7) vaccine's impact on invasive pneumococcal dis...
SummaryBackgroundThe 13-valent pneumococcal conjugate vaccine (PCV13) protects against key serotypes...
BackgroundIn 2000, seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the USA and ...
Background The Streptococcus pneumoniae Invasive Disease network (SpIDnet) actively monitors popula...
We investigated the effect of the 7-valent pneumococcal conjugate vaccine (PCV7) programme in Englan...
BACKGROUND:Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13) has reduced invasi...
International audienceBackground: The long-term benefits of pneumococcal conjugate vaccines (PCVs) r...
BackgroundVaccine-serotype (VT) invasive pneumococcal disease (IPD) rates declined substantially fol...
AbstractBackgroundChanges in serotype distribution have been induced after pneumococcal conjugate va...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
BackgroundIn April 2010, a 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 for use in...
BACKGROUND: Pneumococcal conjugate vaccines (PCVs) have substantially reduced the incidence of invas...
<div><p>Background</p><p>The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into t...
Background: Pneumococcal conjugate vaccines covering 10 (PCV10) and 13 (PCV13) serotypes have been i...
Background: Pneumococcal conjugate vaccines covering 10 (PCV10) and 13 (PCV13) serotypes have been ...
BACKGROUND: The 7-valent pneumococcal conjugate (PCV7) vaccine's impact on invasive pneumococcal dis...
SummaryBackgroundThe 13-valent pneumococcal conjugate vaccine (PCV13) protects against key serotypes...
BackgroundIn 2000, seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the USA and ...
Background The Streptococcus pneumoniae Invasive Disease network (SpIDnet) actively monitors popula...
We investigated the effect of the 7-valent pneumococcal conjugate vaccine (PCV7) programme in Englan...
BACKGROUND:Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13) has reduced invasi...
International audienceBackground: The long-term benefits of pneumococcal conjugate vaccines (PCVs) r...
BackgroundVaccine-serotype (VT) invasive pneumococcal disease (IPD) rates declined substantially fol...
AbstractBackgroundChanges in serotype distribution have been induced after pneumococcal conjugate va...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
BackgroundIn April 2010, a 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 for use in...
BACKGROUND: Pneumococcal conjugate vaccines (PCVs) have substantially reduced the incidence of invas...
<div><p>Background</p><p>The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into t...